The client is an investment firm evaluating a potential Series B investment into a clinical-stage CNS therapeutic company 

• Surveyed the disease landscape and validated the mechanism of action of selected therapeutic approaches

• Evaluated the opportunity and risk associated to the pipeline based on the preclinical and clinical data 

• Financial analysis and company valuation

The client is a seed-stage biotech company developing a GPCR-based digital bio platform

• Interfaced with the R&D and BD teams of the client company to structure a product development roadmap 

• Categorized over 300 candidate proteins by combining the scientific feasibilities and large data sets to generate a short list of 5 relevant proteins with high confidence

• Conducted KOL interviews and prior art search to outline the market opportunity and risks 

The client is a spin-off from a top university developing a programmable biology platform for therapeutic purposes

• Strategized product development and constructed a pitch deck for fundraising

• Orchestrated the seed financing efforts and facilitated investor communication

• Facilitated IP licensing